TY - JOUR
T1 - Udredning, behandling og opfølgning af vulvacancer
AU - Frøding, Ligita Paskeviciute
AU - Zobbe, Vibeke
AU - Fokdal, Lars Ulrik
AU - Niemann, Isa Charlotte Secher
AU - Nøtrup, Trine Jakobi
AU - Kristensen, Elisabeth
AU - Christiansen, Anne Pernille
AU - Loft, Annika
AU - Schnack, Tine Henrichsen
PY - 2019/8/19
Y1 - 2019/8/19
N2 - This review summarises the current guidelines for vulva cancer in Denmark. Vulva cancer is a rare disease. The diagnosis is often delayed, which results in large tumours and regional spread. The most important prognostic factor is inguinal lymph node metastases. Staging and treatment is centralised to two hospitals. Primary treatment is wide local excision combined with removal of either inguinal sentinel nodes or lymphadenectomy. Treatment is associated with considerable morbidity, and supportive care is often necessary. Local curable recurrences are common. Relapses in the groin are associated with a poor prognosis. Thus, long term follow-up is essential. *) On behalf of Dansk Gynækologisk Cancer Gruppe for vulvacancer.
AB - This review summarises the current guidelines for vulva cancer in Denmark. Vulva cancer is a rare disease. The diagnosis is often delayed, which results in large tumours and regional spread. The most important prognostic factor is inguinal lymph node metastases. Staging and treatment is centralised to two hospitals. Primary treatment is wide local excision combined with removal of either inguinal sentinel nodes or lymphadenectomy. Treatment is associated with considerable morbidity, and supportive care is often necessary. Local curable recurrences are common. Relapses in the groin are associated with a poor prognosis. Thus, long term follow-up is essential. *) On behalf of Dansk Gynækologisk Cancer Gruppe for vulvacancer.
M3 - Tidsskriftartikel
C2 - 31495360
SN - 0041-5782
VL - 181
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
IS - 34
ER -